Certified by Founder Lodge 
                                        
                                        Vertex Ventures HC
 
                                                 United States  -  San Francisco, California 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $100,000,000
                                            9 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Vertex Ventures HC is part of a global venture fund network under Vertex Holdings. Vertex Ventures HC invests globally in various sectors of the healthcare industry, including biopharmaceutic
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   Matchpoint Therapeutics | 
                                                            October, 17 ,2022 | Series A | $100,000,000 | 
   GrowthSpace | 
                                                            August, 16 ,2022 | Series B | $25,000,000 | 
   Boundless Bio | 
                                                            May, 17 ,2023 | Series C | $100,000,000 | 
   SpyGlass Pharma, Inc. | 
                                                            July, 11 ,2023 | Series C | $90,000,000 | 
   Septerna | 
                                                            July, 18 ,2023 | Series B | $150,000,000 | 
   EyeBio | 
                                                            November, 15 ,2023 | Series A | $65,000,000 | 
   Neuspera Medical Inc. | 
                                                            July, 16 ,2024 | Series D | $23,000,000 | 
   Indapta Therapeutics | 
                                                            December, 18 ,2024 | Unknown | $22,500,000 | 
   Allay Therapeutics | 
                                                            June, 06 ,2025 | Series D | $57,500,000 | 
                                                
  Matchpoint Therapeutics
  GrowthSpace
  Boundless Bio
  SpyGlass Pharma, Inc.
  Septerna
  EyeBio
  Neuspera Medical Inc.
  Indapta Therapeutics
  Allay Therapeutics
Cherry Ventures
 
                                            
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)